Search Results - Nadaraja, Sambavy

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review

    Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review by Nadaraja, Sambavy, Helsing, Jonas, Naghavi-Behzad, Mohammad, Land, Lotte H., Ruhlmann, Christina H., Gerke, Oke, Hildebrandt, Malene G.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Correction: Value of 2-[18 F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review

    Correction: Value of 2-[18 F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review by Nadaraja, Sambavy, Helsing, Jonas, Naghavi-Behzad, Mohammad, Land, Lotte H., Ruhlmann, Christina H., Gerke, Oke, Hildebrandt, Malene G.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study

    Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study by Nadaraja, Sambavy, Jørgensen, Trine Lembrecht, Matzen, Lars-Erik, Herrstedt, Jørn

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy

    ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy by Nadaraja, Sambavy, Schledermann, Doris, Herrstedt, Jørn, Østrup, Olga, Ditzel, Henrik J.

    Published in Acta oncologica
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The impact of comprehensive geriatric assessment for optimal treatment of older patients with cancer: A randomized parallel-group clinical trial

    The impact of comprehensive geriatric assessment for optimal treatment of older patients with cancer: A randomized parallel-group clinical trial by Nadaraja, Sambavy, Matzen, Lars-Erik, Jørgensen, Trine Lembrecht, Dysager, Lars, Knudsen, Anja Ør, Jeppesen, Stefan Starup, Möller, Sören, Herrstedt, Jørn

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate

    Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate by Nadaraja, Sambavy, Mamoudou, Aissata Diop, Thomassen, Harald, Wehner, Peder Skov, Rosthoej, Steen, Schroeder, Henrik

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: